JPWO2020041502A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020041502A5
JPWO2020041502A5 JP2021509772A JP2021509772A JPWO2020041502A5 JP WO2020041502 A5 JPWO2020041502 A5 JP WO2020041502A5 JP 2021509772 A JP2021509772 A JP 2021509772A JP 2021509772 A JP2021509772 A JP 2021509772A JP WO2020041502 A5 JPWO2020041502 A5 JP WO2020041502A5
Authority
JP
Japan
Prior art keywords
magnetic
magnetic stimulation
seconds
stimulation
stimulator
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021509772A
Other languages
Japanese (ja)
Other versions
JP2021533918A (en
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/047551 external-priority patent/WO2020041502A1/en
Publication of JP2021533918A publication Critical patent/JP2021533918A/en
Publication of JPWO2020041502A5 publication Critical patent/JPWO2020041502A5/ja
Pending legal-status Critical Current

Links

Claims (12)

機能不全の膀胱及び/または腸機能を有する対象の膀胱及び/または腸の排泄または制御を促進するのに充分な位置、周波数及び強度で脊髄の磁気刺激を与えるように配置された磁気刺激装置。 A magnetic stimulator positioned to provide magnetic stimulation of the spinal cord at a location, frequency and intensity sufficient to facilitate bladder and/or bowel emptying or control in a subject with dysfunctional bladder and/or bowel function. 前記機能不全の膀胱及び/または腸が、神経因性膀胱機能障害を含む;または
前記機能不全の膀胱及び/または腸が、術後便秘を含む;または
前記機能不全の膀胱及び/または腸が、麻薬誘発性便秘を含む;または
前記機能不全の膀胱及び/または腸が、オピオイド性便秘を含む;または
前記機能不全の膀胱及び/または腸が、外傷または感染などの炎症性刺激によって誘発される機能不全を含む;または
前記機能不全の膀胱及び/または腸が、妊娠関連膀胱及び/または腸機能障害を含む;または
前記機能不全の膀胱及び/または腸が、
髄膜脊髄瘤、糖尿病、AIDS、アルコール乱用、ビタミンB12欠乏性神経障害、椎間板ヘルニア、骨盤手術による障害、梅毒、及び腫瘍
からなる群から選択される状態に関連している、請求項1に記載の磁気刺激装置。
wherein said dysfunctional bladder and/or bowel comprises neurogenic bladder dysfunction; or said dysfunctional bladder and/or bowel comprises postoperative constipation; or said dysfunctional bladder and/or bowel comprises or wherein said dysfunctional bladder and/or bowel comprises opioid constipation; or wherein said dysfunctional bladder and/or bowel is induced by an inflammatory stimulus such as trauma or infection. or said dysfunctional bladder and/or bowel comprises pregnancy-related bladder and/or bowel dysfunction; or said dysfunctional bladder and/or bowel comprises
2. The method of claim 1, associated with a condition selected from the group consisting of: meningomyelia, diabetes, AIDS, alcohol abuse, vitamin B12 deficient neuropathy, disc herniation, injury from pelvic surgery, syphilis, and tumors. magnetic stimulator.
前記磁気刺激装置が、排尿を誘導するための約0.5Hzから最大約15Hzの範囲の周波数の磁気刺激を与えるように配置される;及び/または
前記磁気刺激装置が、約1Hzの周波数の磁気刺激を与えるように配置される;または
前記磁気刺激装置が、排尿を停止または防止するための約20Hzから最大約100Hzの周波数の磁気刺激を与えるように配置される;または
前記磁気刺激が、排尿を停止または防止するための約30Hzの周波数の磁気刺激を与えるように配置される;または
前記磁気刺激装置が、少なくとも約0.5Hz、1Hz、または少なくとも約2Hz、または少なくとも約3Hz、または少なくとも約4Hz、または少なくとも約5Hz、または少なくとも約10Hz、または少なくとも約20Hzまたは少なくとも約30Hzまたは少なくとも約40Hzまたは少なくとも約50Hzまたは少なくとも約60Hzまたは少なくとも約70Hzまたは少なくとも約80Hzまたは少なくとも約90Hzまたは少なくとも約100Hz、または少なくとも約200Hz、または少なくとも約300Hz、または少なくとも約400Hz、または少なくとも約500Hzの周波数の磁気刺激を与えるように配置される、請求項1または2に記載の磁気刺激装置。
The magnetic stimulation device is arranged to provide magnetic stimulation at a frequency ranging from about 0.5 Hz up to about 15 Hz to induce urination; or said magnetic stimulation device is arranged to provide magnetic stimulation at a frequency of about 20 Hz up to about 100 Hz to stop or prevent urination; or said magnetic stimulation device is arranged to provide magnetic stimulation at a frequency of about 30 Hz for stopping or preventing 4 Hz, or at least about 5 Hz, or at least about 10 Hz, or at least about 20 Hz, or at least about 30 Hz, or at least about 40 Hz, or at least about 50 Hz, or at least about 60 Hz, or at least about 70 Hz, or at least about 80 Hz, or at least about 90 Hz, or at least about 100 Hz, or 3. A magnetic stimulator according to claim 1 or 2, arranged to provide magnetic stimulation at a frequency of at least about 200 Hz, or at least about 300 Hz, or at least about 400 Hz, or at least about 500 Hz.
前記磁気刺激が、約5μsから、または約10μsから、または約15μsから、または約20μsから最大約500μs、または最大約400μs、または最大約300μs、または最大約200μs、または最大約100μs、または最大約50μsの範囲の持続時間の磁気パルスを含む;または
前記磁気パルスの持続時間が約25μsである、請求項1から3のいずれか一項に記載の磁気刺激装置。
The magnetic stimulation is from about 5 μs, or from about 10 μs, or from about 15 μs, or from about 20 μs up to about 500 μs, or up to about 400 μs, or up to about 300 μs, or up to about 200 μs, or up to about 100 μs, or up to about 4. A magnetic stimulator according to any one of claims 1 to 3, comprising a magnetic pulse of duration in the range of 50 [mu]s; or wherein said magnetic pulse has a duration of about 25 [mu]s.
前記磁気刺激が一相性または二相性である、請求項1から4のいずれか1項に記載の磁気刺激装置。 5. The magnetic stimulation apparatus of any one of claims 1-4, wherein the magnetic stimulation is monophasic or biphasic. 前記磁気刺激装置が、1つ、または2つ、または3つ、または4つ、または5つ、または6つ、または7つ、または8つ、または9つ、または10個、またはそれ以上の連続した刺激時間を含む磁気刺激の1回の治療を与えるように配置される;または
前記磁気刺激装置が、約3つの連続した刺激時間を含む磁気刺激の1回の治療を与えるように配置される、請求項1から5のいずれか1項に記載の磁気刺激装置。
1, or 2, or 3, or 4, or 5, or 6, or 7, or 8, or 9, or 10, or more in series or said magnetic stimulation device is arranged to provide one treatment of magnetic stimulation comprising about three consecutive stimulation periods; The magnetic stimulation device according to any one of claims 1 to 5.
前記磁気刺激装置が、持続時間が約10秒から、または約20秒から、または約3秒から、または約40秒から、または約50秒から、または約1分から、または約2分から最大約10分、または最大約8分、または最大約6分の範囲である連続した刺激時間を与えるように配置される;または
前記磁気刺激装置が、持続時間が約4分である連続した刺激時間を与えるように配置される、請求項6に記載の磁気刺激装置。
The magnetic stimulator has a duration of from about 10 seconds, or from about 20 seconds, or from about 3 seconds, or from about 40 seconds, or from about 50 seconds, or from about 1 minute, or from about 2 minutes up to about 10 seconds. minutes, or up to about 8 minutes, or up to about 6 minutes; or said magnetic stimulator provides a continuous stimulation time of about 4 minutes in duration. 7. The magnetic stimulation device of claim 6, arranged to:
前記磁気刺激装置が、約5秒から、または約10秒から、または約15秒から、または約20秒から最大約5分、または最大約4分、または最大約3分、または最大約2分、または最大約1分、または最大約45秒、または最大約30秒の範囲である連続した各刺激時間の間の遅延を与えるように配置される;または
前記磁気刺激装置が、約30秒である連続した各刺激時間の間の遅延を与えるように配置される、請求項6または7に記載の磁気刺激装置。
the magnetic stimulator is from about 5 seconds, or from about 10 seconds, or from about 15 seconds, or from about 20 seconds up to about 5 minutes, or up to about 4 minutes, or up to about 3 minutes, or up to about 2 minutes or arranged to provide a delay between each successive stimulation period ranging up to about 1 minute, or up to about 45 seconds, or up to about 30 seconds; 8. A magnetic stimulator according to claim 6 or 7, arranged to provide a delay between each successive stimulation time.
前記磁気刺激による前記対象の治療がその後になって磁気刺激なしでの随意排泄を促進する磁気刺激を、前記磁気刺激装置が与えるように配置される、請求項1から8のいずれか一項に記載の磁気刺激装置。 9. Any one of claims 1 to 8, wherein the magnetic stimulation device is arranged to provide magnetic stimulation that promotes voluntary voiding without magnetic stimulation after treatment of the subject with the magnetic stimulation. A magnetic stimulator as described. 前記磁気刺激装置が、胸髄及び/または腰仙髄にわたる磁気刺激を適用するように配置される;または
前記磁気刺激装置が、T1~T1、T1~T2、T1~T3、T1~T4、T1~T5、T1~T6、T1~T7、T1~T8、T1~T9、T1~T10、T1~T11、T1~T12、T2~T2、T2~T3、T2~T4、T2~T5、T2~T6、T2~T7、T2~T8、T2~T9、T2~T10、T2~T11、T2~T12、T3~T3、T3~T4、T3~T5、T3~T6、T3~T7、T3~T8、T3~T9、T3~T10、T3~T11、T3~T12、T4~T4、T4~T5、T4~T6、T4~T7、T4~T8、T4~T9、T4~T10、T4~T11、T4~T12、T5~T5、T5~T6、T5~T7、T5~T8、T5~T9、T5~T10、T5~T11、T5~T12、T6~T6、T6~T7、T6~T8、T6~T9、T6~T10、T6~T11、T6~T12、T7~T7、T7~T8、T7~T9、T7~T10、T7~T11、T7~T12、T8~T8、T8~T9、T8~T10、T8~T11、T8~T12、T9~T9、T9~T10、T9~T11、T9~T12、T10~T10、T10~T11、T10~T12、T11~T11、T11~T12、T12~T12、L1~L1、L1~L2 、L1~L3、L1~L4、L1~L5、L1~S1、L1~S2、L1~S3、L1~S4、L1~S5、L2~L2 、L2~L3、L2~L4、L2~L5、L2~S1、L2~S2、L2~S3、L2~S4、L2~S5、L3~L3、L3~L4、L3~L5、L3~S1、L3~S2、L3~S3、L3~S4、L3~S5、L4~L4、L4~L5、L4~S1、L4~S2、L4~S3、L4~S4、L4~S5、L5~L5 、L5~S1、L5~S2、L5~S3、L5~S4、L5~S5、S1~S1、S1~S2、S1~S3、S1~S4、S1~S5、S2~S2、S2~S3、S2~S4、S2~S5、S3~S3、S3~S4、S3~S5、S4~S4、S4~S5、及びS5~S6からなる群から選択される1つ以上の領域にわたる磁気刺激を適用するように配置される;または
前記磁気刺激装置が、T11~L4の間の領域にわたる磁気刺激を適用するように配置される;または
前記磁気刺激装置が、T11~T12、L1~L2、及びL2~L3からなる群から選択される1つ以上の領域にわたる磁気刺激を適用するように配置される;または
前記磁気刺激装置が、L1~L2にわたって及び/またはT11~T12にわたる磁気刺激を適用するように配置される;または
前記磁気刺激が、L1にわたる磁気刺激を適用するように配置される、請求項1から9のいずれか一項に記載の磁気刺激装置。
said magnetic stimulator is arranged to apply magnetic stimulation over the thoracic and/or lumbosacral spinal cord; ~T5, T1~T6, T1~T7, T1~T8, T1~T9, T1~T10, T1~T11, T1~T12, T2~T2, T2~T3, T2~T4, T2~T5, T2~T6 , T2-T7, T2-T8, T2-T9, T2-T10, T2-T11, T2-T12, T3-T3, T3-T4, T3-T5, T3-T6, T3-T7, T3-T8, T3 ~T9, T3~T10, T3~T11, T3~T12, T4~T4, T4~T5, T4~T6, T4~T7, T4~T8, T4~T9, T4~T10, T4~T11, T4~T12 , T5-T5, T5-T6, T5-T7, T5-T8, T5-T9, T5-T10, T5-T11, T5-T12, T6-T6, T6-T7, T6-T8, T6-T9, T6 ~T10, T6~T11, T6~T12, T7~T7, T7~T8, T7~T9, T7~T10, T7~T11, T7~T12, T8~T8, T8~T9, T8~T10, T8~T11 , T8-T12, T9-T9, T9-T10, T9-T11, T9-T12, T10-T10, T10-T11, T10-T12, T11-T11, T11-T12, T12-T12, L1-L1, L1 ~ L2 , L1 ~ L3, L1 ~ L4, L1 ~ L5, L1 ~ S1, L1 ~ S2, L1 ~ S3, L1 ~ S4, L1 ~ S5, L2 ~ L2 , L2 ~ L3, L2 ~ L4, L2 ~ L5 , L2-S1, L2-S2, L2-S3, L2-S4, L2-S5, L3-L3, L3-L4, L3-L5, L3-S1, L3-S2, L3-S3, L3-S4, L3 ~S5, L4~L4, L4~L5, L4~S1, L4~S2, L4~S3, L4~S4, L4~S5, L5~L5, L5~S1, L5~S2, L5~S3, L5~S4 , L5-S5, S1-S1, S1-S2, S1-S3, S1-S4, S1-S5, S2-S2, S2-S3, S2-S4, S2-S5, S3-S3, S3-S4, S3 ~ S5, S4-S4, S4-S5, and S5-S6, arranged to apply magnetic stimulation over one or more regions selected from the group consisting of; or the magnetic stimulation device applies magnetic stimulation over one or more regions selected from the group consisting of T11-T12, L1-L2, and L2-L3. or said magnetic stimulation device is arranged to apply magnetic stimulation across L1-L2 and/or across T11-T12; or said magnetic stimulation applies magnetic stimulation across L1 10. A magnetic stimulation device according to any one of claims 1 to 9, arranged to.
前記磁気刺激装置が、脊髄の正中線での磁気刺激を適用するように配置される、請求項1から10のいずれか一項に記載の磁気刺激装置。 11. A magnetic stimulator according to any preceding claim, wherein the magnetic stimulator is arranged to apply magnetic stimulation at the midline of the spinal cord. 前記磁気刺激装置が、少なくとも約1テスラ、または少なくとも約2テスラ、または少なくとも約3テスラ、または少なくとも約4テスラ、または少なくとも約5テスラの磁場を発生するように配置される、請求項1から11のいずれか一項に記載の磁気刺激装置。 12. The magnetic stimulator is arranged to generate a magnetic field of at least about 1 Tesla, or at least about 2 Tesla, or at least about 3 Tesla, or at least about 4 Tesla, or at least about 5 Tesla. The magnetic stimulator according to any one of .
JP2021509772A 2018-08-21 2019-08-21 Percutaneous electrical and / or magnetic spinal cord stimulation to control the bladder or intestine in subjects without central nervous system damage Pending JP2021533918A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862720835P 2018-08-21 2018-08-21
US62/720,835 2018-08-21
US201962827782P 2019-04-01 2019-04-01
US62/827,782 2019-04-01
PCT/US2019/047551 WO2020041502A1 (en) 2018-08-21 2019-08-21 Transcutaneous electrical and/or magnetic spinal stimulation for bladder or bowel control in subjects without cns injury

Publications (2)

Publication Number Publication Date
JP2021533918A JP2021533918A (en) 2021-12-09
JPWO2020041502A5 true JPWO2020041502A5 (en) 2023-04-20

Family

ID=69591289

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021509772A Pending JP2021533918A (en) 2018-08-21 2019-08-21 Percutaneous electrical and / or magnetic spinal cord stimulation to control the bladder or intestine in subjects without central nervous system damage

Country Status (5)

Country Link
US (1) US20210236837A1 (en)
EP (1) EP3840825A4 (en)
JP (1) JP2021533918A (en)
CA (1) CA3110189A1 (en)
WO (1) WO2020041502A1 (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012094346A2 (en) 2011-01-03 2012-07-12 The Regents Of The University Of California High density epidural stimulation for facilitation of locomotion, posture, voluntary movement, and recovery of autonomic, sexual, vasomotor, and cognitive function after neurological injury
ES2728143T3 (en) 2011-11-11 2019-10-22 Univ California Transcutaneous spinal cord stimulation: non-invasive tool for locomotor circuit activation
DE102012013534B3 (en) 2012-07-05 2013-09-19 Tobias Sokolowski Apparatus for repetitive nerve stimulation for the degradation of adipose tissue by means of inductive magnetic fields
US9993642B2 (en) 2013-03-15 2018-06-12 The Regents Of The University Of California Multi-site transcutaneous electrical stimulation of the spinal cord for facilitation of locomotion
WO2015048563A2 (en) 2013-09-27 2015-04-02 The Regents Of The University Of California Engaging the cervical spinal cord circuitry to re-enable volitional control of hand function in tetraplegic subjects
WO2016029159A2 (en) 2014-08-21 2016-02-25 The Regents Of The University Of California Regulation of autonomic control of bladder voiding after a complete spinal cord injury
US10773074B2 (en) 2014-08-27 2020-09-15 The Regents Of The University Of California Multi-electrode array for spinal cord epidural stimulation
US11491342B2 (en) 2015-07-01 2022-11-08 Btl Medical Solutions A.S. Magnetic stimulation methods and devices for therapeutic treatments
US20180001107A1 (en) 2016-07-01 2018-01-04 Btl Holdings Limited Aesthetic method of biological structure treatment by magnetic field
US10695575B1 (en) 2016-05-10 2020-06-30 Btl Medical Technologies S.R.O. Aesthetic method of biological structure treatment by magnetic field
US11266850B2 (en) 2015-07-01 2022-03-08 Btl Healthcare Technologies A.S. High power time varying magnetic field therapy
US11298533B2 (en) 2015-08-26 2022-04-12 The Regents Of The University Of California Concerted use of noninvasive neuromodulation device with exoskeleton to enable voluntary movement and greater muscle activation when stepping in a chronically paralyzed subject
US11253717B2 (en) 2015-10-29 2022-02-22 Btl Healthcare Technologies A.S. Aesthetic method of biological structure treatment by magnetic field
US11097122B2 (en) 2015-11-04 2021-08-24 The Regents Of The University Of California Magnetic stimulation of the spinal cord to restore control of bladder and/or bowel
US11247039B2 (en) 2016-05-03 2022-02-15 Btl Healthcare Technologies A.S. Device including RF source of energy and vacuum system
US11464993B2 (en) 2016-05-03 2022-10-11 Btl Healthcare Technologies A.S. Device including RF source of energy and vacuum system
US11534619B2 (en) 2016-05-10 2022-12-27 Btl Medical Solutions A.S. Aesthetic method of biological structure treatment by magnetic field
US10583287B2 (en) 2016-05-23 2020-03-10 Btl Medical Technologies S.R.O. Systems and methods for tissue treatment
US10556122B1 (en) 2016-07-01 2020-02-11 Btl Medical Technologies S.R.O. Aesthetic method of biological structure treatment by magnetic field
DE20168827T1 (en) 2017-06-30 2021-01-21 Gtx Medical B.V. NEUROMODULATION SYSTEM
WO2019110400A1 (en) 2017-12-05 2019-06-13 Ecole Polytechnique Federale De Lausanne (Epfl) A system for planning and/or providing neuromodulation
EP3653256B1 (en) 2018-11-13 2022-03-30 ONWARD Medical N.V. Control system for movement reconstruction and/or restoration for a patient
EP3695878B1 (en) 2019-02-12 2023-04-19 ONWARD Medical N.V. A system for neuromodulation
CA3116569C (en) 2019-04-11 2023-08-15 Btl Medical Technologies S.R.O. Methods and devices for aesthetic treatment of biological structures by radiofrequency and magnetic energy
US11517760B2 (en) 2019-05-06 2022-12-06 Kamran Ansari Systems and methods of treating medical conditions using arrays of planar coils configured to generate pulsed electromagnetic fields and integrated into clothing
EP3827871A1 (en) 2019-11-27 2021-06-02 ONWARD Medical B.V. Neuromodulation system
US11878167B2 (en) 2020-05-04 2024-01-23 Btl Healthcare Technologies A.S. Device and method for unattended treatment of a patient
CA3173876A1 (en) 2020-05-04 2021-11-11 Tomas SCHWARZ Device and method for unattended treatment of a patient
US20220151864A1 (en) * 2020-11-19 2022-05-19 Massachusetts Institute Of Technology Systems, Devices, and Methods for Gamma Entrainment using Tactile Stimuli
US11896816B2 (en) 2021-11-03 2024-02-13 Btl Healthcare Technologies A.S. Device and method for unattended treatment of a patient

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6505074B2 (en) * 1998-10-26 2003-01-07 Birinder R. Boveja Method and apparatus for electrical stimulation adjunct (add-on) treatment of urinary incontinence and urological disorders using an external stimulator
US6701185B2 (en) * 2002-02-19 2004-03-02 Daniel Burnett Method and apparatus for electromagnetic stimulation of nerve, muscle, and body tissues
ES2552308T3 (en) * 2009-09-03 2015-11-27 Murdoch Childrens Research Institute Transcutaneous stimulation system
CA2778963A1 (en) * 2009-10-26 2011-05-05 Emkinetics, Inc. Method and apparatus for electromagnetic stimulation of nerve, muscle, and body tissues
US10092750B2 (en) * 2011-11-11 2018-10-09 Neuroenabling Technologies, Inc. Transcutaneous neuromodulation system and methods of using same
DK3082947T3 (en) * 2013-12-22 2019-06-17 Univ City New York Res Found Transspinal DC modulation systems
US20150190634A1 (en) * 2014-01-06 2015-07-09 Ohio State Innovation Foundation Neuromodulatory systems and methods for treating functional gastrointestinal disorders
WO2016029159A2 (en) * 2014-08-21 2016-02-25 The Regents Of The University Of California Regulation of autonomic control of bladder voiding after a complete spinal cord injury
US11097122B2 (en) * 2015-11-04 2021-08-24 The Regents Of The University Of California Magnetic stimulation of the spinal cord to restore control of bladder and/or bowel
US10661094B2 (en) * 2016-04-18 2020-05-26 Wave Neuroscience, Inc. Systems and methods for spasticity treatment using spinal nerve magnetic stimulation

Similar Documents

Publication Publication Date Title
JPWO2020041502A5 (en)
Anderson et al. 6-day intensive treatment protocol for refractory chronic prostatitis/chronic pelvic pain syndrome using myofascial release and paradoxical relaxation training
Graven-Nielsen et al. Quantification of local and referred muscle pain in humans after sequential im injections of hypertonic saline
Rao Biofeedback therapy for constipation in adults
Dalmose et al. Conditional stimulatzion of the dorsal penile/clitoral nerve may increase cystometric capacity in patients with spinal cord injury
Kałka et al. Association between physical exercise and quality of erection in men with ischaemic heart disease and erectile dysfunction subjected to physical training
US7623925B2 (en) Methods for selectively stimulating components in, on, or near the pudendal nerve or its branches to achieve selective physiologic responses
Horvath et al. Conditional and continuous electrical stimulation increase cystometric capacity in persons with spinal cord injury
CN106604760A (en) Electrostimulation related devices and methods
Terra et al. Electrical stimulation and pelvic floor muscle training with biofeedback in patients with fecal incontinence: a cohort study of 281 patients
Bykoviene et al. Pelvic floor muscle training with or without tibial nerve stimulation and lifestyle changes have comparable effects on the overactive bladder. A randomized clinical trial
JPH08505072A (en) A method to relieve urinary or stool tightness, incontinence or vaginal or bladder spasm by changing the strength of human muscles
Ahmed et al. Effect of Pelvic Floor Electrical Stimulation and Biofeedback on the Recovery of Urinary Continence after Radical Prostatectomy.
Kennelly et al. Electrical stimulation of the urethra evokes bladder contractions and emptying in spinal cord injury men: case studies
Chen et al. Pudendal neuromodulation improves voiding efficiency in diabetic rats
Krhut et al. Peroneal electric transcutaneous neuromodulation (eTNM®): a novel method for the treatment of the overactive bladder
Suh et al. Nocturnal penile tumescence and effects of complete spinal cord injury: possible physiologic mechanisms
Rashid et al. Obstructed defecation syndrome: a treatise on its functional variant
Kennelly et al. Electrical stimulation of the urethra evokes bladder contractions in a woman with spinal cord injury
RU2018145443A (en) METHOD FOR COMBINED NON-INVASIVE TREATMENT OF URINE INCIDENCE IN PATIENTS AFTER RADICAL PROSTATECTOMY
RU2321385C2 (en) Method for treating proximal periduodenitis cases
Hošnjak et al. Effectiveness of biofeedback therapy as conservative choice for management of female stress urinary incontinence
RU2038099C1 (en) Method for alleviating spastic syndrome caused by spinal cord segmental disorder
Rahman et al. Comparison the Effectiveness of Manual Therapy, Electrotherapy and Core Stability Exercise vs Electrotherapy, Traction and Traditional Exercise for Acute Low Back Pain
RU2295986C2 (en) Method for carrying out postoperative rehabilitation